Saturday 17 October 2026
Export DHC’s income statement to Excel — free account
Diversified Healthcare Trust
DHC Real Estate Reit Healthcare Facilities
Diversified Healthcare Trust’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 2.84% from fiscal 2024. In the quarter to June 2026, revenue fell 4.53%, EPS grew 57.9%, free cash flow fell 94.0% and total debt fell 8.86%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three; insiders bought in the last twelve months.
7.59
0.02
−0.26%
Follow DHC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 4 | 5 | 1 | 3 | 4 | 3 | 7 | 6 | 6 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 4.18 | 0.00 | 0.00 | 9.77 | 31.03 | 31.77 |
P/S ratio |
0.76 | 0.37 | 0.61 | 0.12 | 0.53 | 0.60 | 1.93 | 2.49 | 4.25 | 4.28 |
P/FCF ratio |
2.76 | 0.00 | 0.00 | 0.70 | 0.00 | 8.31 | 8.12 | 5.66 | 23.09 | 34.37 |
P/Operating CF |
(57.95) | 30.28 | (118.94) | (46.19) | (14.67) | (2,251.69) | 28.58 | 26.06 | 53.96 | 55.11 |
P/B ratio |
0.70 | 0.28 | 0.37 | 0.06 | 0.28 | 0.37 | 0.70 | 0.88 | 1.39 | 1.41 |
Price to Tangible BV |
0.70 | 0.28 | 0.37 | 0.06 | 0.28 | 0.37 | 0.70 | 0.88 | 1.39 | 1.41 |
EV/Sales |
2.53 | 2.52 | 2.75 | 1.96 | 2.45 | 2.87 | 5.68 | 5.69 | 7.63 | 7.75 |
EV/EBITDA |
28.85 | 14.32 | 20.16 | 16.31 | 13.79 | 18.19 | 15.35 | 12.39 | 14.85 | 13.86 |
EV/Operating CF |
(198.51) | 33.52 | 369.87 | (62.37) | (53.61) | 29.58 | 22.23 | 16.19 | 19.54 | 19.32 |
EV/FCF |
9.21 | (68.01) | (18.81) | 11.21 | (18.09) | 39.81 | 23.92 | 12.93 | 41.42 | 62.32 |
Quick Ratio |
2.36 | 4.80 | 8.46 | 0.95 | 1.21 | 1.88 | 1.65 | 1.10 | 0.78 | 1.33 |
Current Ratio |
2.36 | 4.80 | 8.46 | 0.95 | 1.21 | 1.88 | 1.65 | 1.10 | 0.78 | 1.33 |
Net Debt/EBITDA |
16.88 | 10.51 | 13.36 | 15.29 | 10.80 | 14.39 | 10.14 | 7.84 | 6.57 | 6.25 |
Debt/Assets |
55.05% | 56.67% | 51.72% | 50.78% | 55.51% | 58.70% | 59.45% | 57.18% | 50.38% | 51.68% |
Debt/Equity |
1.44 | 1.49 | 1.21 | 1.16 | 1.38 | 1.45 | 1.37 | 1.29 | 1.12 | 1.17 |
Asset Turnover |
0.32 | 0.28 | 0.25 | 0.20 | 0.21 | 0.25 | 0.15 | 0.15 | 0.15 | 0.15 |
Operating CF/Net income |
0.07 | (0.30) | (0.04) | 2.56 | (0.36) | (1.14) | (3.01) | 1.37 | 2.84 | 3.00 |
Capex/Depreciation |
1.30 | (0.43) | (0.73) | 1.07 | (0.45) | (0.15) | (0.07) | 0.35 | (0.80) | (1.01) |
Interest Coverage |
(1.00) | (0.53) | (0.54) | (0.45) | (0.12) | (0.06) | 0.54 | 1.27 | 1.67 | 1.81 |
| (15.78%) | (17.24%) | (11.80%) | (0.60%) | 6.61% | (5.07%) | (2.91%) | 8.89% | 4.56% | 4.31% | |
| (6.02%) | (7.00%) | (5.13%) | (0.25%) | 2.66% | (2.12%) | (1.28%) | 3.97% | 2.03% | 1.96% | |
ROIC |
(3.25%) | (1.67%) | (1.32%) | (1.17%) | (0.37%) | (0.13%) | 0.89% | 1.97% | 2.49% | 2.75% |
Return on Tangible Assets |
(7.27%) | (8.30%) | (5.85%) | (0.33%) | 3.32% | (2.42%) | (1.49%) | 4.52% | 2.32% | 2.22% |
Average Days of Receivables |
0.94 | 0.99 | 1.57 | 2.48 | 0.00 | 0.00 | 0.70 | 6.11 | 6.30 | 6.36 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
2.96% | 1.77% | 1.85% | 2.06% | 2.46% | 1.87% | 3.56% | 7.69% | 9.65% | 4.40% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(2.21) | (5.49) | (3.33) | (16.95) | (4.00) | (3.85) | (1.86) | (1.40) | (0.86) | (0.88) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 13.65 | 0.00 | 0.00 | 19.01 | 13.88 | 13.49 |
Earnings Yield |
(24.54%) | (66.96%) | (34.26%) | (9.09%) | 23.95% | (14.32%) | (4.38%) | 10.24% | 3.22% | 3.15% |
Free Cash Flow Yield |
36.28% | (10.04%) | (24.05%) | 142.71% | (25.52%) | 12.03% | 12.32% | 17.67% | 4.33% | 2.91% |
Revenue per Share |
6.40 | 6.24 | 5.90 | 5.39 | 5.81 | 6.86 | 4.38 | 4.70 | 4.53 | 4.46 |
Operating CF per Share |
(0.08) | 0.47 | 0.04 | (0.17) | (0.27) | 0.67 | 1.12 | 1.65 | 1.77 | 1.79 |
Capex per Share |
1.84 | (0.70) | (0.91) | 1.11 | (0.52) | (0.17) | (0.08) | 0.42 | (0.93) | (1.23) |
Free Cash Flow per Share |
1.76 | (0.23) | (0.86) | 0.94 | (0.79) | 0.50 | 1.04 | 2.07 | 0.83 | 0.55 |
Cash per Share |
0.51 | 0.63 | 1.03 | 2.89 | 4.27 | 0.38 | 0.22 | 0.30 | 0.20 | 0.15 |
Shareholders Equity per Share |
6.93 | 8.18 | 9.78 | 11.07 | 11.19 | 11.02 | 12.11 | 13.39 | 13.80 | 13.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.93 | 8.18 | 9.78 | 11.07 | 11.19 | 11.02 | 12.11 | 13.39 | 13.80 | 13.48 |
Free Cash Flow |
422.79 | (55.31) | (206.17) | 224.47 | (187.67) | 117.82 | 247.03 | 491.93 | 197.87 | 131.61 |
Working Capital |
72.39 | 121.83 | 223.13 | (37.60) | 178.83 | 42.53 | 21.38 | 8.29 | (18.54) | 13.25 |
Capital Expenditures |
442.41 | (167.53) | (216.65) | 264.82 | (124.35) | (40.72) | (18.81) | 99.09 | (221.43) | (292.87) |
Net Current Asset Value |
(2,569.91) | (3,024.25) | (2,856.20) | (2,666.46) | (2,944.18) | (3,766.35) | (3,722.56) | (3,891.78) | (3,950.97) | (3,974.33) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 61.10 | 28.04 | 29.78 | 27.06 |
Capex to Sales |
(0.29) | 0.11 | 0.15 | (0.21) | 0.09 | 0.03 | 0.02 | (0.09) | 0.21 | 0.28 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.73 | 12.27 | 16.60 | 14.93 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.09 | 0.09 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 |
Cash ROIC |
10.09% | (1.10%) | (3.82%) | 3.52% | (2.55%) | 1.81% | 3.59% | 6.70% | 2.83% | 1.89% |
Accounts Receivable Turnover |
383.03 | 295.01 | 190.62 | 239.78 | 0.00 | 0.00 | 100.54 | 60.00 | 58.13 | 58.21 |
Accounts Payable Turnover |
79.48 | 154.09 | 191.49 | 164.65 | 66.54 | 74.20 | 15.51 | 7.48 | 9.32 | 21.43 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
6.58 | 2.65 | 2.20 | 1.71 | 2.76 | 7.25 | 6.55 | 43.89 | 58.62 | 20.36 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
4.02 | 5.07 | 7.40 | 5.35 | — | — | 10.35 | 18.62 | 18.49 | 18.18 |
Average Payables |
15.84 | 8.03 | 6.13 | 6.74 | 16.41 | 16.66 | 31.54 | 60.36 | 44.35 | 18.65 |
Average Assets |
4,749.13 | 5,291.57 | 5,724.11 | 6,312.80 | 6,549.97 | 6,565.13 | 6,907.13 | 7,227.22 | 7,260.89 | 7,193.92 |
Average Common Equity |
1,812.21 | 2,147.87 | 2,487.75 | 2,650.50 | 2,640.81 | 2,748.14 | 3,028.46 | 3,228.53 | 3,238.30 | 3,279.58 |
Columns are period end dates